skip to main content

GLP-1 receptor agonist counselling — GPhC CRA MCQ

Instant feedback + full explanation. One question, done properly.

EasyEndocrine TherapeuticsGLP-1 receptor agonist counsellingGPhC CRA

A patient starts weekly semaglutide for type 2 diabetes. She asks what adverse effects are most likely when treatment begins. What would you advise the patient?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: B — Nausea, reduced appetite and gastrointestinal upset

GLP-1 receptor agonists commonly cause gastrointestinal adverse effects, particularly during dose escalation. Patients should follow the dosing schedule and seek advice if severe or persistent symptoms occur. The other options either delay appropriate care, use an unsuitable medicine, or miss the main safety issue.

Reference: BNF; NICE CKS